English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17775/20116 (88%)
Visitors : 9457239      Online Users : 77
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/30995

    標題: Improving risk assessment and familial aggregation of age at onset in schizophrenia using minor physical anomalies and craniofacial measures
    作者: Tsai, I-Ning
    Lin, Jin-Jia
    Lu, Ming-Kun
    Tan, Hung-Pin
    Jang, Fong-Lin
    Gan, Shu-Ting
    Lin, Sheng-Hsiang
    貢獻者: Natl Cheng Kung Univ, Inst Clin Med, Coll Med
    Chimei Med Ctr, Dept Psychiat
    Jianan Mental Hosp, Dept Hlth
    Chia Nan Univ Pharm & Sci, Dept Appl Life Sci & Hlth
    Kaohsiung Vet Gen Hosp, Tainan Branch, Dept Psychiat
    Chung Hwa Univ Med Technol, Dept Acupressure Technol
    Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth
    Natl Cheng Kung Univ Hosp, Biostat Consulting Ctr
    關鍵字: endophenotype
    familial aggregation
    minor physical anomalies
    neurodevelopmental markers
    recurrence risk ratio
    日期: 2016-07
    上傳時間: 2018-01-18 11:39:28 (UTC+8)
    出版者: Lippincott Williams & Wilkins
    摘要: Age at onset is the most important feature of schizophrenia that could indicate its origin. Minor physical anomalies (MPAs) characterize potential marker indices of disturbances in early neurodevelopment. However, the association between MPAs and age at onset of schizophrenia is still unclear. We aimed to compare risk assessment and familial aggregation in patients with early-onset schizophrenia (EOS) and adult-onset schizophrenia (AOS) with MPAs and craniofacial measures. We estimated the risk assessment of MPAs among patients with EOS (n=68), patients with AOS (n=183), nonpsychotic relatives (n=147), and healthy controls (n=241) using 3 data-mining algorithms. In addition, we assessed the magnitude of familial aggregation of MPAs with respect to the age at onset of schizophrenia. The performance of EOS was superior to that of AOS, with discrimination accuracies of 89% and 76%, respectively. Combined MPA scores as the risk assessment were significantly higher in all schizophrenia subgroups and the nonpsychotic relatives of EOS patients than in the healthy controls. The recurrence risk ratio for familial aggregation of the MPA scores of EOS families (odds ratio 9.27) was substantially higher than that of AOS families (odds ratio 2.47). The results highlight that EOS improves risk assessment and has a severe magnitude of familial aggregation of MPAs. These findings indicate that EOS might result from a stronger genetic susceptibility to neurodevelopmental deficits.
    關聯: Medicine, v.95 n.30, e4406
    Appears in Collections:[生活應用與保健系] 期刊論文

    Files in This Item:

    File Description SizeFormat
    30995.pdf235KbAdobe PDF166View/Open

    All items in CNU IR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback